ESMO Breast 2024 | Defining radiation volumes in post-neoadjuvant therapy: insights from ESMO Breast 2024

Orit Kaidar-Person, MD, Sheba Medical Center, Ramat Gan, Israel, discusses ongoing trials on adapting radiation volumes after primary systemic therapy based on patient response. The goal is to optimize radiation therapy, reduce toxicity for good responders, and intensify therapy for poor responders. This interview took place at the 2024 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress in Berlin, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.